BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee AJ, Wu AG, Yew KC, Shelat VG. Does size matter for resection of giant versus non-giant hepatocellular carcinoma? A meta-analysis. World J Gastrointest Surg 2023; 15(2): 273-286 [PMID: 36896301 DOI: 10.4240/wjgs.v15.i2.273]
URL: https://www.wjgnet.com/1007-9327/full/v15/i2/273.htm
Number Citing Articles
1
Vishal G Shelat. Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapyWorld Journal of Gastrointestinal Oncology 2024; 16(10): 4037-4041 doi: 10.4251/wjgo.v16.i10.4037
2
Xiaodong Zhang, Luyi Zhang, Shuangying Zhao, Lingling Dai, Huayu Li, Xudong Wu, Huanjun Yan, Rongfeng Lin, Kelei Zhu. Tumor marker pseudoprogression and immune-related cholangitis during conversion therapy for massive hepatocellular carcinoma: a case reportFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1529016